MBD2a pcDNA3.1 Citations (2)

Originally described in: Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
Wischnewski F, Friese O, Pantel K, Schwarzenbach H Mol Cancer Res. 2007 Jul;5(7):749-59. PubMed Journal

---

Articles Citing MBD2a pcDNA3.1

Articles
Optochemical Control of TET Dioxygenases Enables Kinetic Insights into the Domain-Dependent Interplay of TET1 and MBD1 while Oxidizing and Reading 5-Methylcytosine. Lin TC, Palei S, Summerer D. ACS Chem Biol. 2022 Jul 15;17(7):1844-1852. doi: 10.1021/acschembio.2c00245. Epub 2022 Jun 16. PubMed
Methyl-CpG binding domain protein 2 (Mbd2) drives breast cancer progression through the modulation of epithelial-to-mesenchymal transition. Mahmood N, Arakelian A, Szyf M, Rabbani SA. Exp Mol Med. 2024 Apr;56(4):959-974. doi: 10.1038/s12276-024-01205-2. Epub 2024 Apr 1. PubMed

If you have published an article using this material, please email us at to have your article added to this page.